Fig. 2
From: Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin
TEM micrograph (A), size distribution (B) and zeta potential analyzed by DLS (HORIBA SZ-100, HORIBA, Kyoto, Japan) of miR34a-Cis-Lip-RGD
Fig. 2 | Cancer Nanotechnology